Bone-Building drug under the microscope: new insights for osteoporosis
NCT ID NCT01293292
First seen May 20, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study looked at how teriparatide, a bone-building drug, works in 19 postmenopausal women with osteoporosis. The goal was to understand the changes in bone density and turnover over two years. The findings could help researchers develop better treatments for osteoporosis in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, South Yorkshire, S5 7AU, United Kingdom
Conditions
Explore the condition pages connected to this study.